Red Blood Cell Transfusions and ARDS Risk in Critically Ill Patients
Author Information
Author(s): Marya D Zilberberg, Chureen Carter, Patrick Lefebvre, Monika Raut, Francis Vekeman, Mei Sheng Duh, Andew F Shorr
Primary Institution: School of Public Health and Health Sciences, University of Massachusetts, Amherst
Hypothesis
pRBC transfusions would be independently associated with the development of ARDS.
Conclusion
Transfusion of pRBCs is independently associated with the development of ARDS in the ICU.
Supporting Evidence
- 246 out of 4730 patients developed ARDS in the ICU.
- 67% of ARDS cases had exposure to pRBC transfusions.
- The unadjusted odds ratio of developing ARDS in transfused patients was 2.74.
- After adjustments, the relationship between pRBC transfusions and ARDS remained significant with an adjusted OR of 2.80.
Takeaway
Giving blood transfusions to very sick patients can make them more likely to get a serious lung problem called ARDS.
Methodology
A cohort study within a multicenter, prospective, observational study of transfusion practice in the ICU.
Potential Biases
Potential inter-observer variability in ARDS diagnosis and lack of data on transfusions prior to ICU admission.
Limitations
The study is retrospective and may be subject to various biases; causation cannot be inferred.
Participant Demographics
Critically ill patients in 284 ICUs across the United States.
Statistical Information
P-Value
p < 0.0001
Confidence Interval
95% CI, 2.09 to 3.59
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website